100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4.2 TrustPilot
logo-home
Examen

Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald

Puntuación
-
Vendido
-
Páginas
830
Grado
A+
Subido en
30-05-2025
Escrito en
2024/2025

Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald Test Bank - Nurse Practitioner Certification Exam Prep 5th Edition by Margaret A. Fitzgerald

Mostrar más Leer menos
Institución
Nurse Practitioner Certification
Grado
Nurse Practitioner Certification











Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Libro relacionado

Escuela, estudio y materia

Institución
Nurse Practitioner Certification
Grado
Nurse Practitioner Certification

Información del documento

Subido en
30 de mayo de 2025
Número de páginas
830
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

Vista previa del contenido

FULL TEST BANK

,Health Promotion
1
n




and Disease Prevention
n n




Primary Prevention M
n n
Activenimmunitynisndefinednas:
resistancendevelopedninnresponsentonannantigen.
easures immunitynconferrednbynannantibodynprodu
cedninnanothernhost.
Annexamplenofnanprimarynpreventionnmeasurenf thenresistancenofnangroupntonanninfectiousnagent.
ornan78-year- defensenagainstndiseasenacquirednnaturallyn
oldnmannwithnchronicnobstructivenpulmonaryndi byntheninfantnfromnthenmother.
seasenis:
A.nreviewingnthenusenofnprescribednmedications. Whichnofnthenfollowingnisnusuallynviewednasnt
conductingnanhomensurveyntonminimizenfallnrisk. henmostncost-effectivenformnofnhealthcare?
checkingnFEV1n(forcenexpirednvolumenatn1nsecon primarynprevention
d)ntonFVCn(forcednvitalncapacity)nratio. secondarynprevention
D.norderingnfecalnoccultnbloodntestn(FOBT). tertiarynprevention
D.ncancer-reductionnmeasures
Whichnofnthenfollowingnisnannexamplenofnanprimary
npreven-tionnactivityninnan76-year- Ann18-year-
oldnwomannwithnosteoporosis?nA.nbisphosphonaten oldnwomannwithnallergicnrhinitisnpresentsnfornprimar
therapy yncare.nShenisnsexuallynactivenwithnanmalenpartnernand
calciumnsupplementation nisn1nyearnpost-

ensuringnadequatenilluminationninnthenhome coitarche;nduringnthisntimenshenhadnhadntwonsexnpart
D.nusenofnanbacknbrace ners.nAnnexamplenofnanprimarynpreventionnactivitynfo
rnthisnpatientnis:
Secondarynpreventionnmeasuresnfornan78-year- A.nscreeningnfornsexuallyntransmittedninfection.
oldnmannwithnchronicnobstructivenpulmonaryndise counselingnaboutnsafernsexualnpractices.
aseninclude:nA.nscreeningnfornmoodndisorders. prescribingntherapiesnfornminimizingnallergy.
administeringninfluenzanvaccine. D.nobtainingnanliquid-basednPapanicolaoun(Pap)ntest.
obtainingnanserumntheophyllinenlevel.
D.nadvisingnaboutnappropriatenusenofncarnpas Whennancriticalnportionnofnancommunitynisnimmunizedn
sengernrestraints. againstnancontagiousndisease,nmostnmembersnofnthenco
m-
Tertiarynpreventionnmeasuresnfornan69-year- munity,nevennthenunimmunized,narenprotectednagainst
oldnwomannwithnheartnfailureninclude: thatndiseasenbecausentherenisnlittlenopportunitynfornan
A.nadministeringnantipneumococcalnvaccine. outbreak.nThisnisnknownnas immunity.
adjustingntherapyntonminimizendyspnea. passive
surveyingnskinnfornprecancerousnlesions. humoral
D.nreviewingnsafenhandlingnofnfood. epidemiologic
nD.ncommunity
Whichnofnthenfollowingnproductsnprovidesnp
assivenimmunity?
A.nhepatitisnBnimmunenglobulinn(HBIG)
measles,nmumps,nandnrubellan(MMR)nvaccine
n Answers
pneumococcalnconjugatenvaccine 1. B. 4. B. 7. A.
D.nlivenattenuatedninfluenzanvaccinen(LAIV) 2. C. 5. A. 8. B.
3. A. 6. A. 9. D.

,2 CnHnAnPnTnEnR 1 ■ HealthnPromotionnandnDiseasenPrevention
http://www.cdc.gov/excite/skincancer/mod13.htm,nCentersn
fornDiseasenControlnandnPrevention:nLevelsnofnPreventio
Primarynpreventionnmeasuresnincludenactivitiesnprovidedntonin
n
dividualsntonpreventnthenonsetnornacquisitionnofnangivenndiseas
http://www.niaid.nih.gov/topics/pages/communityimmunity.aspx,
e.nThengoalnofnprimarynpreventionnmeasuresnisntonsparenindivi nNationalnInstitutenofnAllergynandnInfectiousnDisease:nCommu
dualsnthensuffering,nburden,nandncostnassociatednwithnthenclini nitynImmunity
calnconditionnandnisnthenfirstnlevelnofnhealthcare.nAnnex-
amplenisnhealth-
protectingneducationnandncounseling,nsuchnasnencouragingnthe
nusenofncarnrestraintsnandnbicyclenhelmets,ncounselingnaboutnsa

fernsexualnpractices,nandnprovidingninfor-
mationnonnaccidentnandnfallnprevention.nGivennitsnfocusnonnpre
ventingnillnessnorninjury,nprimarynpreventionnisnusuallynviewe
dnasnthenmostneffectivenformnofnhealthcare.
Immunizationsnandnchemoprophylaxisnarenalsonexam-
plesnofnprimarynpreventionnmeasures.nActivenimmunizationnth
roughnthenusenofnvaccinesnprovidesnlong-
termnprotectionnfromndisease.nInnherdnorncommunitynimmunit
y,nansignificantnportionnofnangivennpopulationnhasnimmunityna
gainstnanninfec-
tiousnagent;nthenlikelihoodnthatnthensusceptiblenportionnofntheng
roupnwouldnbecomeninfectednisnminimizedn(Fig.n1–1).nPas-
sivenimmunitynisnprovidednwhennanpersonnreceivesnselectnan-
tibodies,nusuallynvianthenadministrationnofnimmunenglobulinn(I
G),nafternexposurentonanninfectivenagent.nThisnimmunitynisntem
porarynandnrequiresnthenpatientntonpresentnpost-
exposure;nthenprotectionnprovidednbynIGnusuallynstartsnwithinn
hoursnofnreceivingnthendosesnandnlastsnannumbernofnmonths.nT
henusenofnvaccinesntonproducenlastingndiseasenprotectionnisnpre
ferredntonpassivenimmunizationnthroughnthenusenofnIG.nAnothe
rnexam-
plenofnpassivenimmunitynisnthenacquisitionnofndiseasenprotec-
tionnprovidednfromnmotherntonunbornnchildnvianthenplacenta.nS
econdarynpreventionnmeasuresnincludenactivitiesnprovidedntoni
dentifynandntreatnasymptomaticnpersonsnwhonhavenrisknfac-
torsnfornangivenndiseasenorninnpreclinicalndisease.nExamplesnin-
cludenscreeningnexaminationsnfornpreclinicalnevidencenofncance
r,nsuchnasnmammographynandncervicalnexaminationnwithnanPa
panicolaountest.nOthernexamplesnofnsecondarynpreventionnactiv
itiesnincludenscreeningnfornclinicalnconditionsnwithnanpro-
tractednasymptomaticnperiod,nsuchnasnanbloodnpressurenmeas-
urementntondetectnhypertensionnandnanlipidnprofilentondetectnh
yperlipidemian(Tablen1–1).


Seenfullncolornimagesnofnthisnto
picnonnDavisPlusnatnhttp://davi
splus.fadavis.comn|nKeywor
d:nFitzgerald

Tertiarynpreventionnmeasuresnarenpartnofnthenmanagementn
ofnannestablishedndisease.nThengoalnisntonminimizendisease-
associatedncomplicationsnandnthennegativenhealthneffectsnofnthe
nconditionsntonthenpatient.nExamplesnincludenmedicationsnandn

lifestylenmodificationntonnormalizenbloodnglucosenlevelsninnind
ividualsnwithndiabetesnmellitusnandninnconjunctionnwithnthentr
eatmentnofnheartnfailure,naimednatnimprovingnornmini-
mizingndisease-relatednsymptoms.

DISCUSSIONnSOURCES

, Thenprimarynindicationnisninnpreventingninflue
nzanAnduringnoutbreaks.
Influenza ThendrugsnarenactivenonlynagainstninfluenzanB.
Immunization D.nThenusenofnthesenmedicationsnisnannacceptable
nalter-nativentoninfluenzanvaccine.


Whennadvisingnanpatientnaboutninjectableninfluenzanim
-
munization,nthennursenpractitionern(NP)nconsidersnthen
followingnaboutnthenusenofnthisnvaccine:
A.nItsnusenisnnotnrecommendedninnsicklencellnanemia.
Ȁ ⸀Ā ̀Ā ĀĀȀ ̀Ā ȀȀ⸀Ā ᜀ Ā ᜀ
tsnusenisnlimitedntonchildrennoldernthann2nyears.
Ȁ ⸀Ā ̀Ā ĀĀȀ ̀Ā ȀȀ⸀Ā ᜀ Ā ᜀ
tsnusenisnlimitednduentoncontainingnlivenvirus.
D.nItsnusenisnrecommendednfornvirtuallynallnmem
bersnofnthenpopulation.
Anmiddle-
agednmannwithnchronicnobstructivenpul-
monaryndiseasenwhonisnaboutntonreceiveninjectable
nin-fluenzanvaccinenshouldnbenadvisednthat:

A.nitnisnmorenthann90%neffectiveninnpreventingninfluenza
.
itsnusenisncontraindicatedninnthenpresencenofnpsori
asisnvulgaris.
localizednreactionsnsuchnasnsorenessnandnrednessnatnt
hensitenofnthenimmunizationnarenfairlyncommon.
D.nanshort,nintense,nflulikensyndromentypicallyn
occursnafternimmunization.
An44-year-
oldnwomannwithnasthmanpresentsnaskingnfornan“flunsh
ot.”nShenisnseenntodaynfornannurgentncarenvisit,nisndiagn
osednwithnanlowernurinaryntractninfection,nandnisnpresc
ribedntrimethoprim-
sulfamethoxazole.nShenisnwithoutnfevernorngastrointesti
nalnupsetnwithnstablenrespiratorynstatus.nYouninformnh
ernthatnshe:
shouldnreturnnfornthenimmunizationnafternco
mplet-ingnhernantibioticntherapy.
wouldnlikelyndevelopnansignificantnreactionnifni
mmu-nizedntoday.
cannreceiventhenimmunizationntoday.
D.nisnnotnancandidatenfornanynformnofninfluenzanvaccine.

Whichnofnthenfollowingnstatementsnbestndescribe
snamantadinenornrimantadinenuseninnthencarenofn
patientsnwithnornatnrisknforninfluenza?
Significantnresistancentonselectnstrainsnofninfluenzanli
mitsnthenusefulnessnofnthesenmedications.
Thenprimarynactionnofnthesentherapiesnisninnprev
ent-ingninfluenzanAnduringnoutbreaks.
ThesentherapiesnarenactivenagainstninfluenzanAnandnB.
Thenusenofnthesenproductsnisnannacceptablenalter
nativentoninfluenzanvaccine.
Whichnofnthenfollowingnstatementsnbestndescribesnza
namivirn(Relenza)nornoseltamivirn(Tamiflu)nuseninnth
encarenofnpatientsnwithnornatnrisknforninfluenza?
Initiationnofntherapynearlyninnacuteninfluenzanillnes
sncannhelpnminimizenthenseveritynofndiseasenwhennt
henillnessnisncausednbynannonresistantnviralnstrain.
$14.48
Accede al documento completo:

100% de satisfacción garantizada
Inmediatamente disponible después del pago
Tanto en línea como en PDF
No estas atado a nada

Conoce al vendedor

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
ameliashamash Harvard University
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
66
Miembro desde
1 año
Número de seguidores
2
Documentos
1310
Última venta
3 semanas hace

3.1

9 reseñas

5
4
4
0
3
1
2
1
1
3

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes